Evaluation of Hepatoprotective and Hepatotoxic Activities of Root Extracts of Cyperus pertenuis in Rats
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 15, Issue 6
Abstract
Aim of Study: The present study was conducted to assess the role of root extracts of Cyperus pertenuis (CP) in its ability to protect liver cells alongside the evaluation of its hepatotoxic effects if any. Methodology: Dried powdered roots (1kg) of CP were macerated in ethanol (5 L) for five days. The residue obtained after filtration was then macerated in n-hexane (2 L) for 5 days. Both filtrates were concentrated by rotavapor to semi-solid pastes and in-vitro anti-oxidant activity was found by 2,2–Diphenyl–1¬–Picrylhydrazyl (DPPH) method. 42 rats were placed in seven groups (n=6). Group-I (vehicle control) was administered with 5% Carboxymethyl cellulose (CMC), Group-II (disease control) was given paracetamol (1 g/kg/p.o) for seven days. Group-III (standard) was administered with silymarin (25 mg/kg/p.o) for seven days. Groups IV–VII were given plant extracts in different doses for seven days prior to administration of paracetamol. Blood was collected 18 hours after administration of paracetamol and serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Alkaline Phosphatase (ALP) and Total Bilirubin (TB) were assessed. Moreover, toxicity and histopathological studies were also performed. Results: In disease control group, the levels of ALT, AST, ALP and TB were observed as 174.5±1.8 u/l, 215.7±5.4 u/l, 689.8±9.1 u/l and 1±.06 mg/dl, respectively which were reduced significantly to 146.7±3.3 u/l, 139.5±6.5 u/l, 508.3±3.2 u/l and .81±.04 mg/dl in plant treated group (400 mg/kg/p.o). Necrotic lesions were observed in histopathological slides of disease control group while extract treated liver were free of necrosis and other structural damages. LD50 calculated for plant extract was 3162 mg/kg/p.o. Conclusion: It is thus concluded that C. pertenuis root extract is a potent hepatoprotective agent and shows hepatotoxicity only at very high doses.
Authors and Affiliations
Aamir Mushtaq, Shehla Rehmat, Mehwish Jamil, Asifa Bashir, Qurat-Ul- Ain, Habib Anwar, Sarah Rashid
Fed Bioequivalence Studies for Immediate Release Drug Products: Beneficial or Wastage?
Aims: The present study was undertaken to understand the need of fed bioequivalence studies for immediate release pharmaceutical products and thereby evaluating the relative appropriateness of guidelines given by the Eur...
Anti-inflammatory Effects and Acute Toxicity of Methanol Stem Bark Extract of Morus mesozygia Stapf.
Aim: Morus mesozygia is a specie of the Morus family in Africa that is traditionally used for the treatment of rheumatism. Until this moment, there is no available literature on the scientific evidence of the in vivo ant...
Formulation and Characterization of Solid Lipid Nanoparticles Containing Artemether and Lumefantrine for Treatment of P. falciparum
Objective: To investigate sustained release of solid lipid nanoparticles containing Artemether and Lumefantrine against the P. falciparum by the combination of drugs that eventually will decrease the chance of drug resis...
A Validated Liquid Chromatographic Method for the Determination of Rifampicin and Isoniazid in Pharmaceutical Formulations
A simple RP-HPLC method with more accuracy and precission was developed for determination of Rifampicin and Isoniazid simultaneously. A mobile phase consisted of methanol, acetonitrile and water in the ratio 60:20:20(v/v...
Rapid, Simple and Validated Method for Estimation of Zolpidem by UPLC in Tablet Dosage Form
Aim: To create and approve a novel and fast RP-UPLC technique for the estimation of zolpidem in tablet dosage form. Place and Duration of Study: Department of pharmaceutical analysis, S.V.S. school of Pharmacy, Bheemaram...